PL2948179T3 - Kompozycje zawierające nanocząstki tlenku hafnu(iv) lub tlenku renu(iv) w połączeniu z promieniowaniem jonizującym do leczenia nowotworu - Google Patents
Kompozycje zawierające nanocząstki tlenku hafnu(iv) lub tlenku renu(iv) w połączeniu z promieniowaniem jonizującym do leczenia nowotworuInfo
- Publication number
- PL2948179T3 PL2948179T3 PL14701965T PL14701965T PL2948179T3 PL 2948179 T3 PL2948179 T3 PL 2948179T3 PL 14701965 T PL14701965 T PL 14701965T PL 14701965 T PL14701965 T PL 14701965T PL 2948179 T3 PL2948179 T3 PL 2948179T3
- Authority
- PL
- Poland
- Prior art keywords
- oxide
- rhenium
- hafnium
- nanoparticles
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
- A61N2005/1087—Ions; Protons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
- A61N2005/1089—Electrons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361756533P | 2013-01-25 | 2013-01-25 | |
| EP13305087 | 2013-01-25 | ||
| PCT/EP2014/051367 WO2014114732A1 (en) | 2013-01-25 | 2014-01-24 | Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer |
| EP14701965.7A EP2948179B1 (en) | 2013-01-25 | 2014-01-24 | Compositions comprising nanoparticles of hafnium (iv) oxide or rhenium (iv) oxide in combination with ionizing radiations for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2948179T3 true PL2948179T3 (pl) | 2019-10-31 |
Family
ID=47710064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14701965T PL2948179T3 (pl) | 2013-01-25 | 2014-01-24 | Kompozycje zawierające nanocząstki tlenku hafnu(iv) lub tlenku renu(iv) w połączeniu z promieniowaniem jonizującym do leczenia nowotworu |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US10098952B2 (pl) |
| EP (1) | EP2948179B1 (pl) |
| JP (2) | JP6619231B2 (pl) |
| KR (2) | KR102225239B1 (pl) |
| CN (1) | CN105120897B (pl) |
| AR (1) | AR094577A1 (pl) |
| AU (1) | AU2014209899B2 (pl) |
| BR (1) | BR112015017490A2 (pl) |
| CA (2) | CA2897362C (pl) |
| CY (1) | CY1121838T1 (pl) |
| EA (1) | EA034242B1 (pl) |
| HK (1) | HK1216609A1 (pl) |
| IL (1) | IL239767B (pl) |
| MA (1) | MA38318A1 (pl) |
| MX (1) | MX369664B (pl) |
| PL (1) | PL2948179T3 (pl) |
| RS (1) | RS59042B1 (pl) |
| SG (1) | SG11201505277VA (pl) |
| SI (1) | SI2948179T1 (pl) |
| TW (1) | TW201442726A (pl) |
| UA (1) | UA116007C2 (pl) |
| WO (1) | WO2014114732A1 (pl) |
| ZA (1) | ZA201505510B (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102025743B1 (ko) | 2011-12-16 | 2019-09-26 | 나노비오?스 | 금속성 및 산화하프늄 소재를 포함하는 나노입자, 이의 제조 및 용도 |
| WO2014114732A1 (en) | 2013-01-25 | 2014-07-31 | Nanobiotix | Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer |
| EP2886128A1 (en) * | 2013-12-20 | 2015-06-24 | Nanobiotix | Pharmaceutical composition comprising nanoparticles, preparation and uses thereof |
| AR104806A1 (es) | 2015-05-28 | 2017-08-16 | Nanobiotix | Nanopartículas para uso como vacuna terapéutica |
| CA3047651A1 (en) * | 2016-12-21 | 2018-06-28 | Nanobiotix | Nanoparticles for use for enhancing brain performances or for treating stress |
| CA3047649A1 (en) * | 2016-12-21 | 2018-06-28 | Nanobiotix | Nanoparticles for use for treating a neuronal disorder |
| EP3424533A1 (en) * | 2017-07-05 | 2019-01-09 | Nh Theraguix | Methods for treating tumors |
| US11173325B2 (en) * | 2017-07-21 | 2021-11-16 | Varian Medical Systems, Inc. | Methods of use of ultra-high dose rate radiation and therapeutic agent |
| EP3996750A4 (en) | 2019-07-12 | 2024-01-03 | Univ Oregon Health & Science | THERAPEUTIC CONSTRUCTS FOR SIMULTANEOUS ADMINISTRATION OF MITOTIC HIBITOR AND IMMUNE CHECKPOINT INHIBITOR |
| US20220249389A1 (en) | 2019-07-12 | 2022-08-11 | Oregon Health & Science University | Immunotherapeutic constructs and methods of their use |
| WO2021011496A1 (en) * | 2019-07-12 | 2021-01-21 | Oregon Health & Science University | Immunotherapeutic constructs and methods of their use |
| EP4141110A1 (en) | 2020-04-24 | 2023-03-01 | Obshchestvo S Ogranichennoy Otvetstvennost'yu "Ingenik" | Method for producing particles of bacteriophages of the genus levivirus |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000006244A2 (en) | 1998-07-30 | 2000-02-10 | Hainfeld James F | Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
| JP2004513184A (ja) * | 2000-11-20 | 2004-04-30 | オンコリティクス バイオテック， インコーポレイティッド | 固形腫瘍塊への最適なウイルス送達法 |
| US6756063B2 (en) * | 2001-03-29 | 2004-06-29 | Zoltan Laboratories, Llc | Methods and compositions for the treatment of human and animal cancers |
| FR2884149B1 (fr) * | 2005-04-12 | 2007-06-08 | Henri Mehier | Tube implantable destine a l'injection notamment de fluide caloporteur dans tout ou partie d'un tissu humain ou animal |
| EP2130553A1 (en) * | 2008-06-05 | 2009-12-09 | Nanobiotix | Inorganic nanoparticles of high density to destroy cells in-vivo |
| US8395131B2 (en) * | 2009-06-20 | 2013-03-12 | Xiaodong Wu | Method for three dimensional (3D) lattice radiotherapy |
| EP2275137A1 (en) | 2009-07-10 | 2011-01-19 | Nanobiotix | Metallic nanoparticles, preparation and uses thereof |
| US20130225901A1 (en) | 2010-04-05 | 2013-08-29 | Nanospectra Biosciences, Inc. | Enhancement of radiation therapy by targeted high-z nanoparticles |
| KR102025743B1 (ko) | 2011-12-16 | 2019-09-26 | 나노비오?스 | 금속성 및 산화하프늄 소재를 포함하는 나노입자, 이의 제조 및 용도 |
| WO2014114732A1 (en) | 2013-01-25 | 2014-07-31 | Nanobiotix | Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer |
-
2014
- 2014-01-24 WO PCT/EP2014/051367 patent/WO2014114732A1/en active Application Filing
- 2014-01-24 SI SI201431254T patent/SI2948179T1/sl unknown
- 2014-01-24 MX MX2015009409A patent/MX369664B/es active IP Right Grant
- 2014-01-24 EA EA201591378A patent/EA034242B1/ru not_active IP Right Cessation
- 2014-01-24 KR KR1020157022940A patent/KR102225239B1/ko active IP Right Grant
- 2014-01-24 UA UAA201508289A patent/UA116007C2/uk unknown
- 2014-01-24 RS RS20190848A patent/RS59042B1/sr unknown
- 2014-01-24 PL PL14701965T patent/PL2948179T3/pl unknown
- 2014-01-24 CA CA2897362A patent/CA2897362C/en active Active
- 2014-01-24 AR ARP140100222A patent/AR094577A1/es unknown
- 2014-01-24 BR BR112015017490A patent/BR112015017490A2/pt not_active Application Discontinuation
- 2014-01-24 KR KR1020217006350A patent/KR102385193B1/ko active IP Right Grant
- 2014-01-24 JP JP2015554149A patent/JP6619231B2/ja active Active
- 2014-01-24 CN CN201480006025.0A patent/CN105120897B/zh active Active
- 2014-01-24 US US14/762,971 patent/US10098952B2/en active Active
- 2014-01-24 CA CA3179586A patent/CA3179586A1/en active Pending
- 2014-01-24 AU AU2014209899A patent/AU2014209899B2/en active Active
- 2014-01-24 MA MA38318A patent/MA38318A1/fr unknown
- 2014-01-24 TW TW103102786A patent/TW201442726A/zh unknown
- 2014-01-24 SG SG11201505277VA patent/SG11201505277VA/en unknown
- 2014-01-24 EP EP14701965.7A patent/EP2948179B1/en active Active
-
2015
- 2015-07-02 IL IL239767A patent/IL239767B/en active IP Right Grant
- 2015-07-31 ZA ZA2015/05510A patent/ZA201505510B/en unknown
-
2016
- 2016-04-19 HK HK16104483.8A patent/HK1216609A1/zh unknown
-
2018
- 2018-06-06 JP JP2018108835A patent/JP2018168162A/ja active Pending
- 2018-09-13 US US16/129,851 patent/US11020480B2/en active Active
-
2019
- 2019-07-17 CY CY20191100762T patent/CY1121838T1/el unknown
-
2021
- 2021-05-27 US US17/331,674 patent/US11819548B2/en active Active
-
2023
- 2023-11-16 US US18/510,716 patent/US20240100163A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2948179T3 (pl) | Kompozycje zawierające nanocząstki tlenku hafnu(iv) lub tlenku renu(iv) w połączeniu z promieniowaniem jonizującym do leczenia nowotworu | |
| IL276428A (en) | A preparation and vaccine for the treatment of lung cancer | |
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| IL245281A0 (en) | Methods and preparations for the treatment of cancer | |
| SG11201510751YA (en) | Composition and vaccine for treating prostate cancer | |
| HK1225647A1 (zh) | 用於治療癌症的組合物和方法 | |
| EP3004395A4 (en) | Compositions and methods for treating cancer | |
| PL3071192T3 (pl) | Związek kurkufenol do zastosowania w leczeniu nowotworu | |
| IL246065A0 (en) | Valiprib in combination with carboplatin for the treatment of triple negative breast cancer | |
| EP2984185A4 (en) | Methods and compositions for treating cancer | |
| LT2948179T (lt) | Kompozicijos, apimančios hafnio (iv) oksido arba renio (iv) oksido nanodaleles, skirtos vėžio gydymui kartu su jonizuojančia spinduliuote | |
| EP2971044A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER | |
| PL3035955T3 (pl) | Kompozycja i szczepionka do leczenia raka płuca | |
| EP2968398A4 (en) | MODIFIED HYALURONAN AND USES THEREOF IN CANCER TREATMENT | |
| GB201322958D0 (en) | Uses of oligouronates in cancer treatment |